Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hepatitis C, Chronic × Introns × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Hepatitis C, Chronic 1 Conjunctival Intraepithelial Neoplasia 1 Carcinoma, Hepatocellular 1

Interventions

Ribavirin 3 peginterferon alfa-2a 2 sofosbuvir-velpatasvir drug combination 1 ledipasvir 1 Sofosbuvir 1 Introns 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00375661 2015-09-02

Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC

Kyoto University Hospital

Phase 4 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡